US Patent 11597932 Chirally-enriched double-stranded RNA agents
Patent 11597932 was granted and assigned to Alnylam Pharmaceuticals on March, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11597932 Chirally-enriched double-stranded RNA agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
